to determine if replacement therapy would influence the course of autoimmune disease , we injected groups of nzb/w mice with low-dose ( 1,500 units/day ) or high-dose ( 15,000 units/day ) purified human recombinant il-2 .
C0086418
human
C0021756
recombinant il-2